What we should consider to facilitate recovery of the hematological profile in all patients after pancreaticoduodenectomy: the role of preoperative intravenous iron treatment

Table 2 Comparative analysis of clinical outcomes

Variables		Preoperative IV iron	No IV iron	p-value
Variables		n = 30 (46.9%)	n = 34 (53.1%)	p-value
Perioperative outcome
Operative time (min)		354.6 ± 46	328.3 ± 67.1	0.071
Estimated blood loss (ml)		410 ± 450	390 ± 490	0.799
Length of ICU stay (day)		1.4 ± 0.7	1.1 ± 0.4	0.093
Length of hospital stay (day)		11 ± 6.1	11.5 ± 4.1	0.750
Postoperative transfusion		4 (13.3)	9 (26.5)	0.228
Postoperative morbidities (%)		13 (43.3)	13 (38.2)	0.800
Complication grade^** (%)	Grade I/II	10 (33.3)	10 (29.4)	0.791
	Grade III/IV/V	3 (10)	3 (8.8)	1.000
In hospital mortality (%)		0	1 (2.9)	1.000

^**Postoperative morbidities were reviewed and classified according to the Clavien-Dindo classification (14). In complications grading system by Clavien-Dindo classification, grade I and II are considered as minor, and grade III to V are defined as major complications

ISSN: 1471-2482